DK537785D0 - FLAVOLIGNAN DERIVATIVES AND THEIR PREPARATION AND USE - Google Patents

FLAVOLIGNAN DERIVATIVES AND THEIR PREPARATION AND USE

Info

Publication number
DK537785D0
DK537785D0 DK537785A DK537785A DK537785D0 DK 537785 D0 DK537785 D0 DK 537785D0 DK 537785 A DK537785 A DK 537785A DK 537785 A DK537785 A DK 537785A DK 537785 D0 DK537785 D0 DK 537785D0
Authority
DK
Denmark
Prior art keywords
flavolignan
derivatives
preparation
flavolignan derivatives
Prior art date
Application number
DK537785A
Other languages
Danish (da)
Other versions
DK164865C (en
DK537785A (en
DK164865B (en
Inventor
R Braatz
K Goerler
G Halbach
H Soicke
K Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of DK537785D0 publication Critical patent/DK537785D0/en
Publication of DK537785A publication Critical patent/DK537785A/en
Publication of DK164865B publication Critical patent/DK164865B/en
Application granted granted Critical
Publication of DK164865C publication Critical patent/DK164865C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
DK537785A 1984-11-22 1985-11-21 SILIBINE INGREDIATES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SILIBIN INGREDIENTS DK164865C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (en) 1984-11-22 1984-11-22 FLAVOLIGNANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3442639 1984-11-22

Publications (4)

Publication Number Publication Date
DK537785D0 true DK537785D0 (en) 1985-11-21
DK537785A DK537785A (en) 1986-05-23
DK164865B DK164865B (en) 1992-08-31
DK164865C DK164865C (en) 1993-01-18

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
DK537785A DK164865C (en) 1984-11-22 1985-11-21 SILIBINE INGREDIATES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SILIBIN INGREDIENTS

Country Status (29)

Country Link
JP (1) JPS61143377A (en)
KR (1) KR870001020B1 (en)
AR (1) AR240931A1 (en)
AT (1) AT393268B (en)
BE (1) BE903693A (en)
CA (1) CA1337124C (en)
CH (1) CH659473A5 (en)
CS (1) CS273610B2 (en)
DD (1) DD259191A1 (en)
DE (1) DE3442639A1 (en)
DK (1) DK164865C (en)
EG (1) EG19424A (en)
ES (1) ES8609311A1 (en)
FI (1) FI84064C (en)
FR (1) FR2573427B1 (en)
GB (1) GB2167414B (en)
HU (1) HU195503B (en)
IE (1) IE58791B1 (en)
IT (1) IT1190426B (en)
LU (1) LU86163A1 (en)
MX (1) MX168415B (en)
NL (1) NL192387C (en)
NO (1) NO160205C (en)
PL (1) PL146890B1 (en)
PT (1) PT81532B (en)
SE (1) SE465676B (en)
SU (1) SU1436875A3 (en)
YU (1) YU43689B (en)
ZA (1) ZA858951B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
JP5380069B2 (en) * 2005-03-11 2014-01-08 ハワード フローリー インスティチュート Flavonoid compounds and uses thereof
ES2662700T3 (en) 2007-11-15 2018-04-09 Madaus Gmbh Silibinin component for hepatitis treatment
RU2482844C2 (en) * 2007-11-15 2013-05-27 Мадаус Гмбх Silibilin component for treating hepatitis
ES2593858T3 (en) * 2009-05-14 2016-12-13 Madaus Gmbh Method to prepare amorphous silibinin
US20150174093A1 (en) 2012-07-05 2015-06-25 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and magnesium
CN103193768B (en) * 2013-02-22 2016-03-30 西安安健药业有限公司 The silybin bis-bias succinate isomer for the treatment of hepatopathy
CN103172622B (en) * 2013-02-22 2015-11-04 西安安健药业有限公司 The active isomer of silybin bis-bias succinate
CN103113359B (en) * 2013-02-22 2016-01-06 西安安健药业有限公司 Silybin bis-bias succinate and pharmaceutical salts thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (en) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybin esters with hepotoprotactant acti- - vity

Also Published As

Publication number Publication date
ATA337185A (en) 1991-02-15
ES549116A0 (en) 1986-09-01
EG19424A (en) 1995-02-28
BE903693A (en) 1986-05-22
AT393268B (en) 1991-09-25
IT1190426B (en) 1988-02-16
YU178685A (en) 1988-02-29
ES8609311A1 (en) 1986-09-01
NO160205B (en) 1988-12-12
KR870001020B1 (en) 1987-05-23
GB2167414B (en) 1989-01-11
AR240931A1 (en) 1991-03-27
CS837885A2 (en) 1990-08-14
NL192387B (en) 1997-03-03
FI84064C (en) 1991-10-10
PT81532A (en) 1985-12-01
DE3442639A1 (en) 1986-05-22
DK164865C (en) 1993-01-18
DK537785A (en) 1986-05-23
NL192387C (en) 1997-07-04
MX168415B (en) 1993-05-24
PL256374A1 (en) 1986-12-02
NO160205C (en) 1989-03-22
FI854535A (en) 1986-05-23
FR2573427B1 (en) 1989-03-10
JPH0432073B2 (en) 1992-05-28
GB2167414A (en) 1986-05-29
FI84064B (en) 1991-06-28
DD259191A1 (en) 1988-08-17
AR240931A2 (en) 1991-03-27
DE3442639C2 (en) 1989-08-10
NO854655L (en) 1986-05-23
SU1436875A3 (en) 1988-11-07
SE8505487D0 (en) 1985-11-20
CH659473A5 (en) 1987-01-30
NL8503171A (en) 1986-06-16
HU195503B (en) 1988-05-30
CS273610B2 (en) 1991-03-12
SE8505487L (en) 1986-05-23
YU43689B (en) 1989-10-31
IE852808L (en) 1986-05-22
KR860004056A (en) 1986-06-16
JPS61143377A (en) 1986-07-01
PT81532B (en) 1987-11-11
PL146890B1 (en) 1989-03-31
SE465676B (en) 1991-10-14
LU86163A1 (en) 1986-03-24
HUT40114A (en) 1986-11-28
FR2573427A1 (en) 1986-05-23
ZA858951B (en) 1986-08-27
CA1337124C (en) 1995-09-26
FI854535A0 (en) 1985-11-18
IT8522932A0 (en) 1985-11-21
DK164865B (en) 1992-08-31
GB8528226D0 (en) 1985-12-18
IE58791B1 (en) 1993-11-17

Similar Documents

Publication Publication Date Title
DK559985A (en) 13BETA-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK289886A (en) SUBSTITUTED 3-PHENYL-4-CYANOPYRROL DERIVATIVES AND THEIR PREPARATION AND USE
DK211582A (en) ARYLPHENYLETHER DERIVATIVES AND THEIR PREPARATION AND USE
DK520285D0 (en) 5-AMINO-4-HYDROXYVALYLE RELEASE DERIVATIVES AND THEIR PREPARATION AND USE
DK317588A (en) 2-ANILINO-PYRIMIDINE DERIVATIVES AND THEIR PREPARATION AND USE
DK578185A (en) 13BETA-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK29686D0 (en) 13BETA-ALKYL-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK420785A (en) 13-HALOGEN OR 13-HYDROXYMIL BEMYCINES AND THEIR PREPARATION AND USE
DK614084D0 (en) MILBEMYCIM DERIVATIVES AND THEIR PREPARATION AND USE
DK294684A (en) N-ALKYLERED 3-PHENYL-4-CYANOPYRROL DERIVATIVES AND THEIR PREPARATION AND USE
DK537785A (en) FLAVOLIGNAN DERIVATIVES AND THEIR PREPARATION AND USE
DK297082A (en) SUBSTITUTED 1-AZOLYL-2-HYDROXY ALKANDER DERIVATIVES AND THEIR PREPARATION AND USE
DK558484A (en) MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK297182A (en) SUBSTITUTED 2-HYDROXY-3-AZOLYL PROPANDER DERIVATIVES AND THEIR PREPARATION AND USE
DK393285D0 (en) SUBSTITUTED CARBONYLPHENYLSULPHONYLGUANIDINES AND THEIR PREPARATION AND USE
DK236585A (en) ACYLED HEXOSIDE DERIVATIVES AND THEIR PREPARATION AND USE
DK172486A (en) HETEROCYCLYL-PENEM COMPOUNDS AND THEIR PREPARATION AND USE
DK119585D0 (en) 1,2,4-TRIAZACYCLOALCADIA DERIVATIVES AND THEIR PREPARATION AND USE
DK422685D0 (en) BENZAZOLD DERIVATIVES AND THEIR PREPARATION AND USE
DK153285D0 (en) BENZODIOXOLD DERIVATIVES AND THEIR PREPARATION AND USE
DK77286A (en) 1-0-ACYLED HEXOSIDE DERIVATIVES AND THEIR PREPARATION AND USE
DK181485A (en) 3-SUBSTITUTED THIOPYRONS AND THEIR PREPARATION AND USE
DK361185A (en) 2-AMINOALKYL-2-PENEM COMPOUNDS AND THEIR PREPARATION AND USE
DK437986D0 (en) 1-AMINO-3-PHENYL-PROPAN-2-OL-DERIVATIVES AND THEIR PREPARATION AND USE
DK117587D0 (en) 5-ACYLOXY-13BETA-ALKYL-MILBEMYCIN DERIVATIVES AND THEIR PREPARATION AND USE

Legal Events

Date Code Title Description
PBP Patent lapsed